We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Sandbox GGC4
From Proteopedia
(Difference between revisions)
| Line 24: | Line 24: | ||
The <scene name='75/752268/Pax6_c_domain/2'>C-terminal domain</scene> of PAX6 binds to the major groove of DNA, with the 6th and final helix of the C-terminal domain helix-turn-helix motif binds directly to the major groove, serving as a recognition site to guide the C-terminal domain to dock with the sugar phosphate backbone<ref name="structure" />. | The <scene name='75/752268/Pax6_c_domain/2'>C-terminal domain</scene> of PAX6 binds to the major groove of DNA, with the 6th and final helix of the C-terminal domain helix-turn-helix motif binds directly to the major groove, serving as a recognition site to guide the C-terminal domain to dock with the sugar phosphate backbone<ref name="structure" />. | ||
| + | Similarly, the N-terminal domain forms bonds with one of the major grooves of the DNA strand, however there is a beta-hairpin at the beginning of the structure that docks in the minor groove of the DNA<ref name="structure" />. | ||
The <scene name='75/752268/Linker_bound_minor_groove/2'>extended linker region</scene> between the N-terminal and C-terminal domains of PAX6 consists of 15 residues and binds with the sugar phosphate backbone in the minor groove of the DNA being transcribed<ref name="structure" />. | The <scene name='75/752268/Linker_bound_minor_groove/2'>extended linker region</scene> between the N-terminal and C-terminal domains of PAX6 consists of 15 residues and binds with the sugar phosphate backbone in the minor groove of the DNA being transcribed<ref name="structure" />. | ||
Revision as of 13:52, 20 November 2019
Pax6 paired domain protein
| |||||||||||
References
- ↑ Wang X, Shan X, Gregory-Evans CY. A mouse model of aniridia reveals the in vivo downstream targets of Pax6 driving iris and ciliary body development in the eye. Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):60-67. doi:, 10.1016/j.bbadis.2016.10.018. Epub 2016 Oct 20. PMID:27771509 doi:http://dx.doi.org/10.1016/j.bbadis.2016.10.018
- ↑ Stuart ET, Kioussi C, Gruss P. Mammalian Pax genes. Annu Rev Genet. 1994;28:219-36. doi: 10.1146/annurev.ge.28.120194.001251. PMID:7893124 doi:http://dx.doi.org/10.1146/annurev.ge.28.120194.001251
- ↑ 3.0 3.1 3.2 3.3 Xu HE, Rould MA, Xu W, Epstein JA, Maas RL, Pabo CO. Crystal structure of the human Pax6 paired domain-DNA complex reveals specific roles for the linker region and carboxy-terminal subdomain in DNA binding. Genes Dev. 1999 May 15;13(10):1263-75. PMID:10346815
- ↑ 4.0 4.1 4.2 4.3 Parekh, M., Poli, B., Ferrari, S., Teofili, C., & Ponzin, D. (Eds.). (2015). Aniridia : Recent developments in scientific and clinical research DOI: 10.1007/978-3-319-19779-1
- ↑ Duncan MK, Haynes JI 2nd, Cvekl A, Piatigorsky J. Dual roles for Pax-6: a transcriptional repressor of lens fiber cell-specific beta-crystallin genes. Mol Cell Biol. 1998 Sep;18(9):5579-86. doi: 10.1128/mcb.18.9.5579. PMID:9710641 doi:http://dx.doi.org/10.1128/mcb.18.9.5579
- ↑ Vasilyeva TA, Voskresenskaya AA, Kasmann-Kellner B, Khlebnikova OV, Pozdeyeva NA, Bayazutdinova GM, Kutsev SI, Ginter EK, Semina EV, Marakhonov AV, Zinchenko RA. Molecular analysis of patients with aniridia in Russian Federation broadens the spectrum of PAX6 mutations. Clin Genet. 2017 Dec;92(6):639-644. doi: 10.1111/cge.13019. Epub 2017 Aug 2. PMID:28321846 doi:http://dx.doi.org/10.1111/cge.13019
- ↑ 7.0 7.1 Lee HJ, Colby KA. A review of the clinical and genetic aspects of aniridia. Semin Ophthalmol. 2013 Sep-Nov;28(5-6):306-12. doi: 10.3109/08820538.2013.825293. PMID:24138039 doi:http://dx.doi.org/10.3109/08820538.2013.825293
- ↑ Lim HT, Kim DH, Kim H. PAX6 aniridia syndrome: clinics, genetics, and therapeutics. Curr Opin Ophthalmol. 2017 Sep;28(5):436-447. doi: 10.1097/ICU.0000000000000405. PMID:28598868 doi:http://dx.doi.org/10.1097/ICU.0000000000000405
